Form 4: Xeris Biopharma Holdings Director, Marla Persky, Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Marla Persky, a director of Xeris Biopharma Holdings, reports the acquisition of 50,000 restricted stock units and the disposal of 6,370 shares held indirectly through a revocable trust.

Summary

  • On June 5, 2024, Marla Persky, a director of Xeris Biopharma Holdings, Inc., reported a transaction involving the company's stock.
  • Persky acquired 50,000 shares of common stock through a restricted stock unit award under the company's 2018 Stock Option and Incentive Plan.
  • These restricted stock units represent a contingent right to receive one share of Xeris Biopharma Holdings' common stock each.
  • The shares will vest in full on the earlier of June 5, 2025, or the date of the company's next annual meeting of stockholders.
  • Additionally, Persky disposed of 6,370 shares held indirectly through the Marla Susan Persky Revocable Trust u/a dated 9/23/2000.
  • Following these transactions, Persky directly owns 107,500 shares and indirectly owns no shares through the trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The acquisition of restricted stock units is a positive sign, but the disposal of shares held in trust tempers the overall sentiment.

Positives

  • The acquisition of restricted stock units aligns the director's interests with the company's long-term performance.

Negatives

  • The disposal of 6,370 shares, although indirect, could be perceived negatively by some investors.

Risks

  • The vesting of the restricted stock units is contingent upon continued service or the occurrence of the next annual meeting, introducing a time-based risk.

Future Outlook

The director's future ownership will be influenced by the vesting of the restricted stock units and any subsequent transactions.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates a director's continued investment in the company's future.

Stakeholder Impact

  • The transaction may have a minor impact on shareholder sentiment, depending on how the disposal of shares is perceived.

Next Steps

  • Monitor future Form 4 filings by Marla Persky for any further changes in beneficial ownership.
  • Track the vesting date of the restricted stock units.

Key Dates

DateDescription
9/23/2000Date of the Marla Susan Persky Revocable Trust u/a
06/05/2024Date of the transaction: acquisition of restricted stock units and disposal of shares
06/05/2025Date of potential vesting of restricted stock units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.